QLife
Qlife's core patent granted in Europe
The key feature of the innovation is the ability to perform analysis in a microenvironment with fixed alignment, so no variability is seen between analysis and readout.
"This core patent protects how we make a highly integrated and miniaturized home micro-lab the size of a coffee mug. Normally, these mechanical elements are engineered separately, which makes a much bigger device and generates issues related to the variability of the analysis and alignment problems. Because of a highly integrated design that eliminates these issues, Egoo is not only small but also delivers laboratory-quality data, which is quite an engineering achievement. It is also an important design feature for addressing the home diagnostics market; we have all, over the years, learned that the design element of high-tech products should not be underestimated. People, patients, and nurses are not able to carry big laboratory equipment home during admissions at home, but rather a small, portable device that still provides safe and lab-quality diagnostic results," says Thomas Warthoe, CEO of Qlife.
The new patent is already carried on to international markets beyond Europe and provides Qlife with a robust intellectual property position as the company moves towards commercialization.
Datum | 2024-02-23, kl 13:48 |
Källa | Cision |
![](https://static.allaaktier.se/ads/hand-waving-2.png)